Skip to main content
. 2021 Aug 17;26(3):709–718. doi: 10.1007/s10461-021-03430-6

Table 2.

Characteristics of indexes (participants) (N = 371) and partnerships (N = 836) by index race and HIV transmission potential (TPP) in the Understanding Sexual Health in Networks Study (USHINE), Baltimore City, July 2018-March 2020

Black index
N = 270
Non-Black index
N = 101
Any HIV TPP
N = 76 (28.2%)
No HIV TPP
N = 194 (71.9%)
Any HIV TPP
N = 18 (17.8%)
No HIV TPP
N = 83 (82.2%)
Index Level N % N % p-value N % N % p-value
Age ≥ 25 years 59 77.6 137 70.6 0.245 14 77.8 62 74.7 0.784
 > High school graduation 23 39.6 106 50.0 0.162 8 80.0 83 91.2 0.260
Sex partners, past three months, median (IQR) 3 (2.5) 2 (3.0) 0.217 3 (3) 3 (4) 0.845
Non-injection drug use, past three months 29 38.2 65 33.5 0.442 7 38.9 28 33.7 0.677
Injection drug use, past three months 11 14.5 12 6.2 0.027 4 22.2 6 7.2 0.054
HIV positive2 49 64.5 75 38.7  < 0.001 9 50.0 11 13.3  < 0.001
Syphilis positive3 16 21.1 21 10.8 0.029 1 5.6 4 4.8 0.837
Chlamydia and/or gonorrhea positive4 14 18.4 39 20.1 0.700 2 11.1 19 22.9 0.543
Black index partnerships
N = 586
Non-Black index partnerships
N = 250
HIV TPP
N = 132 (22.5%)
No HIV TPP
N = 454 (77.5%)
HIV TPP
N = 28 (11.2%)
No HIV TPP
N = 222 (88.8%)
Partnership Level N % N % p-value N % N % p-value
Age difference (> ± 5 years) 53 40.2 174 38.3 0.259 14 50.0 105 47.30 0.421
Condomless anal intercourse, last sex 78 59.1 294 64.8 0.234 17 60.7 171 77.0 0.060
Partner HIV serostatus5  < 0.001  < 0.001
HIV negative 43 32.6 315 69.4 5 17.9 199 89.6
HIV positive 1 0.8 99 21.8 2 7.1 20 9.0
HIV unknown  88 66.7 40 8.8 21 75.0 3 1.4
Sex partner concurrency6 108 81.8 285 62.8  < 0.001 21 75.0 149 67.1 0.124

1Defined as a partnership between an HIV positive index with an HIV negative or HIV unknown partner or vice versa. If the index reported he or his partner was on PrEP or ARTs, the partnership was not coded as an HIV transmission risk partnership regardless of the partner’s HIV serostatus

2Determined by an HIV rapid test with ELISA confirmation, medical record documentation, or in a few cases, participant self-report

3Defined as a rapid plasma reagin (RPR) titer greater than 1:8 in combination with a positive treponemal test

4Determined by nucleic acid amplification test (NAAT)

5Determined by index self-report

6Determined by index self-report of whether their partner was having sex with other people while having sex with them